11 NOVEMBER 2021
|
| ADULT HEMATOLOGY PROGRAM |
07.40-08.40
|
ORAL PRESENTATION SESSIONS 1
|
Anıl Tombak, Hüseyin Saffet Beköz,Şebnem İzmir Güner
|
|
ADULT & PEDIATRIC ONCOLOGY JOINT SESSION JOINT SESSION IN BASIC ONCOLOGY
|
CHAIRS: Nikolay Tupitsyn - Nur Olgun |
08.40-09.00
|
Genetic Predisposition to Pediatric Cancer
|
Uğur Özbek
|
09.00-09.20
|
Precision Medicine in Cancer
|
Ferda Pınarlı
|
09.20-09.40
|
Inflammation and Cancer | Jean Francois Rossi |
09.40-10.00
|
Cancer Stem Cells: Theories and Facts | Bob Gale |
10.00-10.20
| GENERAL DISCUSSION Chair: Safiye Aktaş
|
|
| 10.20-10.40 | COFFEE BREAK
|
|
ADULT & PEDIATRIC HEMATOLOGY JOINT SESSION IN HAEMOGLOBINOPATHIES
|
CHAIRS: Domenica Capellini - Zeynep Karakaş |
10.40-11.00
|
Evaluation of Iron Load in Patients with Haemoglobinopathy
|
Yeşim Aydınok
|
11.00-11.20
|
"BMT in Children with Thalassemia in Turkey"
|
Akif Yeşilipek
|
11.20-11.40
|
Thalassemia Treatment
|
Domenica Capellini
|
11.40-12.00
|
Treatment of Sickle Cell in 2021
|
Salam Al Kindi
|
12.00-12.20
|
GENERAL DISCUSSION Chair: Göksel Leblebisatan |
| 12.20-13.20 | LUNCH BREAK
|
13.20-14.00
|
SATELLITE SYMPOSIUM-Carfilzomib in the Treatment of Relaps Refractory Multiple Myeloma
 |
CHAIRS: Hakan Göker - SPEAKER: Anıl Tombak |
14.00-14.40
|
SATELLITE SYMPOSIUM
Response, Control and Survival with Ruxolitinib in Myelofibrosis
Polycythemia Vera Management with Ruxolitinib
 |
CHAIRS: Sevgi Kalayoğlu Beşışık - SPEAKER: Ömür Gökmen Sevindik
Mehmet Hilmi Doğu |
|
SESSION 9 - CHRONIC MYELOID LEUKEMIA
|
CHAIRS: Naeem Chaudhri - Emin Kaya |
14.40-15.00
|
Treatment of Resistant Disease with Registered TKI
|
Naeem Chaudhri
|
15.00-15.20
|
How Can We Implement TFR in Clinical Practice?
|
Carmen Fava
|
15.20-15:40
|
Innovative Treatment Options
|
Andreas Hochhaus
|
15.40-16.00
|
Still a Role for IFN in CML?
|
Tomasz Sacha
|
16.00-16.20
| GENERAL DISCUSSION Chair: Levent Ündar
| |
16.20-16.40
|
COFFEE BREAK
|
|
SESSION 10 - MULTIPLE MYELOMA
|
CHAIRS: Ahmad Ibrahim - Zahit Bolaman |
16.40-17.00
|
MRD Detection in MM: Methods and Prognostic Significance
|
Evangelos Terpos
|
17.00-17.20
|
Treatment of Relapsed, Refractory Multiple Myeloma: Focus on New Drugs
|
Angelo Maiolino
|
| 17.20-17.40 |
First Line Therapy for Multiple Myeloma: Open Issues |
Maria-Victoria Mateos |
| 17.40-18.00 |
Management of Waldenstrom Macroglobulinemia in 2020 |
Ahmad Ibrahim |
18.00-18.20
| GENERAL DISCUSSION Chair: Sevgi Kalayoğlu Beşışık |
|
18.20-19.00
|
SATELLITE SYMPOSIUM - Optimal Treatment With IMIDs in MM
 |
CHAIRS: Birol Güvenç SPEAKER: Tülin Tuğlular Maria Mateos |
| 19.00-19.40 |
E-POSTER PRESENTATIONS SESSION 1 |
Mehmet Ali Uçar,Müzeyyen Aslaner |
